Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246815 · ClinicalTrials.gov registry record
STD Testing in Outpatient Practices
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 6,771
- Enrollment target
NCT03246815: Completed study, sponsored by University of Pittsburgh.
NCT03246815 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 6,771 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03246815 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 6,771 participants
- Enrollment target
Study Summary
National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women are not being screened for STDs, with some estimates that less than 50% of women receiving health care are screened for chlamydia. Untreated STDs can lead to important sequelae to women's reproductive health including pelvic inflammatory disease, infertility and ectopic pregnancy. One of the most important barriers to widespread STD screening is provider failure to recognize an opportunity for STD screening. The goal of this study is to determine whether offering STD screening (chlamydia and gonorrhea) by a non-physician member of the medical practice (who receives an automated alert indicating STD screening should be offered) will be associated with a higher rate of STD screening in young women attending primary care practices compared to usual care (where a physician offers screening with no electronic alert). This study will be performed in UPMC-affiliated primary care practices (Family Practice, Internal Medicine, OB/GYN, Pediatrics). Practices will be assigned to the intervention or usual care. The intervention will be an auto-task in the electronic medical record to the non-physician/NP/PA medical staff (medical assistants, LPNs, RNs) to offer chlamydia and gonorrhea screening via urine or self-collected vaginal sampling, in an opt-out manner, to eligible women. Practices assigned to the usual care group will not have the intervention. STD screening rates (# women undergoing STD screening/# eligible women) will be compared between the to groups (intervention practices and control practices). Results of this study may be important to guide national STD screening recommendations and will address critical barriers to widespread STD screening.
Primary Outcome
Rate of screening (Chlamydia and Gonorrhea) in young women attending primary care practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,771 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2020-12-30 |
What the finished NCT03246815 record still lists
NCT03246815 is an observational study that tracks outcomes without assigning an intervention. Its 6,771 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03246815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03246815 about?
NCT03246815 is a clinical study titled "STD Testing in Outpatient Practices". National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women are not being screened for STDs, with some estimates that less than 50% of women receiving health care are screene...
What is the current status of trial NCT03246815?
This trial is currently completed. The enrollment target is 6,771 participants. The study started on 2017-06-12. Estimated completion is 2020-12-30.
Who is sponsoring clinical trial NCT03246815?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT06234384 · 6,833 participants
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI